SEC 8-K
SEC 8-K: Item 1.01, 2.03, 9.01
Official SEC filing update. Items: 1.01, 2.03, 9.01.
Item 1.01, 2.03, 9.01Accession 0001193125-26-282845
Agilent Technologies (A) Financials, Dividends & Stock Info
Explore comprehensive financial data for Agilent Technologies, provided completely free. Analyze revenue, net income, profit margins, dividend history, and key financial ratios to make informed investment decisions.
Data as of (206 days ago)|Source: SEC EDGAR
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
Agilent Technologies (A) is a life sciences tools & services company. The company reports annual revenue of $6.9B and net income of $1.3B. Its profit margin is 18.8%.
Agilent Technologies Key Financials
Revenue (TTM)↑ 6.7%
$6.9B
Net Income (TTM)↑ 1.1%
$1.3B
Profit Margin
18.8%
Top 23% in sector
Data from SEC EDGAR filings. TTM = Trailing Twelve Months.
Agilent Technologies Financial Health ScoreFY2025
0/100
Strong financial position with minor areas to watch
-2 pts YoYProfitability83Liquidity100Solvency85Growth65Cash Flow90Efficiency63
This Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Agilent Technologies Official SEC Updates
Official filing updates from SEC EDGAR. Billiver stores internal evidence snapshots for verification, but this page links to the SEC source instead of republishing full filing text.
Open SEC filing
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001090872-26-000055
SEC 8-K
SEC 8-K: Item 2.02, 5.02, 9.01
Official SEC filing update. Items: 2.02, 5.02, 9.01.
Item 2.02, 5.02, 9.01Accession 0001090872-26-000052
SEC 8-K
SEC 8-K: Item 5.02, 7.01, 9.01
Official SEC filing update. Items: 5.02, 7.01, 9.01.
Item 5.02, 7.01, 9.01Accession 0001193125-26-202636
SEC 8-K/A
SEC 8-K/A: Item 5.02, 9.01
Official SEC filing update. Items: 5.02, 9.01.
Item 5.02, 9.01Accession 0001193125-26-142673
Source: SEC EDGAR · 5 filings
Informational only. Not investment advice.
Agilent Technologies Recent Events
Material Agreement
Leadership Change
Earnings Results
Leadership Change
Leadership ChangeAmended
Source: SEC EDGAR 8-K Filings
5-Year Revenue & Net Income Trend
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
About Agilent Technologies
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting IPO of Agilent stock was the largest in the history of Silicon Valley at the time. From 1999 to 2014, the company produced optics, semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government (research) markets.
- Industry
- Life Sciences Tools & Services
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Positive MarginsProfit Margin18.8%
vs 14.4% sector median / 7.5% avg
▼
Keeps 19 cents of every dollar in revenue as profit. Higher than 77% in Health Care.
Revenue (TTM)$6.9B
5th consecutive year of revenue growth.
Net Income (TTM)$1.3B
Profit margin 151% above sector average.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Balance Sheet Data LimitedInsufficient data to assess financial health.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Agilent Technologies 10-Year Revenue, Profit & Cash Flow History
Net income reached a record high of $1.3B in FY2025.
Annual Financials
FY2025 - FY2016| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.9B(+6.7%) | $6.5B(+3.0%) | $6.3B(+18.4%) | $5.3B(+3.4%) | $5.2B(+5.1%) | $4.9B(-4.8%) | $5.2B(+22.9%) | $4.2B(+4.1%) | $4.0B(-3.9%) | $4.2B(+7.9%) |
| Net Income | $1.3B(+1.1%) | $1.3B(+6.5%) | $1.2B(+68.3%) | $719.0M(-32.9%) | $1.1B(+238.9%) | $316.0M(-70.5%) | $1.1B(+131.8%) | $462.0M(+15.2%) | $401.0M(-13.2%) | $462.0M(-37.1%) |
| Total Assets | $12.7B | $11.8B | $10.5B | $10.5B | $10.7B | $9.6B | $9.5B | $8.5B | $8.4B | $7.8B |
| Total Debt | $3.0B | $3.3B | $2.7B | $2.7B | $2.7B | $2.3B | $1.8B | $1.8B | $1.8B | $1.9B |
| Total Equity | $6.7B | $5.9B | $5.3B | $5.3B | $5.4B | $4.9B | $4.7B | $4.6B | $4.8B | $4.2B |
| Profit Margin | 18.8% | 19.8% | 19.1% | 13.5% | 20.7% | 6.4% | 20.7% | 11.0% | 9.9% | 11.0% |
| ROE | 19.3% | 21.9% | 22.8% | 13.6% | 19.9% | 6.5% | 22.6% | 10.1% | 8.3% | 10.9% |
| ROA | 10.2% | 10.9% | 11.5% | 6.8% | 10.0% | 3.3% | 11.3% | 5.4% | 4.8% | 5.9% |
Quarterly Financials
Last 8 quarters| Metric | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3B | $1.7B | $4.8B | $1.7B | $1.7B | $5.1B | $1.6B | $1.6B |
| Net Income | $533.0M | $318.0M | $938.0M | $336.0M | $215.0M | $765.0M | $282.0M | $308.0M |
| Total Assets | $12.7B | $12.7B | $11.8B | $12.2B | $12.2B | $10.8B | $11.0B | $10.9B |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Insider Trading
Loading chart...
Loading transactions...
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
Agilent Technologies Dividend Safety Analysis & Growth History
Dividend Status
Dividend PayerCAGR (5Y)
+12.4%
CAGR (10Y)
+12.2%
This company pays dividends. Historical dividend data shown below.
6 consecutive years of dividend increases. 5-year dividend CAGR: +12.4%.
Annual Dividends
2016 - 2025| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend/Share | $0.46 | $0.53 | $0.60 | $0.51 | $0.55 | $0.60 | $0.65 | $0.69 | $0.72 | $0.99 |
| YoY Growth | +46.0% | +14.8% | +12.9% | -14.8% | +9.1% | +7.9% | +7.9% | +6.4% | +5.0% | +37.8% |
| Payments | 1 | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Increased | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes |
Learn more: Dividend investing guide | How to evaluate dividend safety
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Agilent Technologies Free Cash Flow & Dividend Coverage
Free Cash Flow
$1.2B
FY2025
FCF Margin
16.6%
FCF / Revenue
Operating Cash Flow
$1.6B
Cash from operations
FCF / Net Income
0.88x
Below earnings
Generates approximately $3M in free cash flow per day.
Cash Flow History
FY2016 - FY2025| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | $793.0M | $512.0M | $793.0M | $1.0B | $1.1B | $1.0B | $921.0M | $1.5B | $1.8B | $1.6B |
| CapEx | -$139.0M | -$98.0M | -$139.0M | -$155.0M | -$177.0M | -$155.0M | -$119.0M | -$188.0M | -$378.0M | -$407.0M |
| Free Cash Flow | $654.0M | $414.0M | $654.0M | $866.0M | $910.0M | $866.0M | $802.0M | $1.3B | $1.4B | $1.2B |
| FCF Margin | 15.6% | 10.3% | 15.6% | 16.8% | 18.5% | 16.8% | 15.0% | 20.5% | 21.1% | 16.6% |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Agilent Technologies Risk Factors
Company-disclosed SEC risk factors
Risk factors are disclosed by the company in its SEC Form 10-K, Item 1A. Billiver does not classify or summarize company-specific legal, operational, financial, or market risks here.
Sector context: Health Care. This is not a Billiver risk assessment for A.
Source note: the SEC Form 10-K includes Item 1A, "Risk Factors." The full risk-factor text should be read from the company’s own SEC filing.
Agilent Technologies FAQ
What is Agilent Technologies's annual revenue?
Agilent Technologies (A) reported $6.9 billion in trailing twelve-month (TTM) revenue. This financial data is compiled from SEC EDGAR 10-K filings.
Is Agilent Technologies profitable?
Yes, Agilent Technologies is profitable with a 18.8% net profit margin and $1.3 billion in net income (TTM). All figures from SEC EDGAR 10-K filings.
Does Agilent Technologies pay dividends?
Yes, Agilent Technologies pays regular dividends with 6 consecutive years of dividend payments. View the full dividend history and payout analysis on this page.
What is Agilent Technologies's financial health score?
Agilent Technologies has a financial health score of 81/100 (Grade: A), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of Agilent Technologies financial data are available?
10 years of financial data are available for Agilent Technologies from FY2016 to FY2025. All figures are compiled from SEC EDGAR 10-K filings.